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Abstract
Background: Integrating HIV/AIDS and methadone maintenance treatment (MMT) services with existing health
care delivery system is critical in sustaining efforts to fight HIV/AIDS in large injection-driven epidemics. However,
efficiency of different integrative service models is unknown. This study assessed behavioral and health-related
quality-of-life (HRQOL) outcomes of MMT in four service delivery models and explored factors associated with these
outcomes of interest.
Methods: A cross-sectional survey was conducted in two HIV epicenters in Vietnam: Hanoi and Nam Dinh Province.
All patients in five selected MMT clinics were invited to participate, and 1016 were interviewed (80–90 % response
rate).
Results: Respondents had a mean age of 35.8, taken MMT for average 16.5 months and 3.3 % on MMT for
36–60 months. The MMT integrated with rural district health center (DHC) has the highest prevalence of
concurrent drug use (11.3 %). The percentage of condom use (last sexual intercourse) with primary and casual partners
was lowest in the MMT at urban DHCs. Patients at the rural DHC reported very high proportions of pain/discomfort
(37.8 %), anxiety/depression (43.1 %), and mobility (13.3 %). In regression models, poorer HRQOL outcomes were found
in MMT models in the rural areas or without general health care, and among those patients who were HIV positive,
reported concurrent drug use, and had higher numbers of previous drug rehabilitation episodes. Mobility and anxiety/
depression are factors that increased the likelihood of concurrent drug use among MMT patients.
Conclusions: Outcomes of MMT were diverse across different integrative service models. Policies on rapid expansion
of the MMT program in Vietnam should also emphasize on the integration with comprehensive health care services
including psychological supports for patients.
Background
In Asia, since injecting illicit drugs is recognized as a
major risk factor for acquiring HIV, opioid substitution
treatments have been considered an important compo-
nent of HIV/AIDS prevention strategies [1–4]. Methadone
maintenance therapy (MMT) has been widely used as a
cost-effective intervention for opioid dependence. Evi-
dences demonstrate the positive effects of MMT on
people who use drugs (PWUD) by reducing the frequency
of HIV-related behaviors and promoting health care ac-
cess, health status, and HIV treatment outcomes [5–11].
Methadone has been included in the list of essential medi-
cine for opioid management by the World Health
Organization (WHO) in 2004 [12].
Along with HIV/AIDS, opioid illicit drug use was
linked to other physical and psychological problems as
well as high risk of mortality [6, 13–18]. Given the needs
of PWUD for comprehensive medical care, the concept
of integrating MMT with general health care services
was proposed [9, 19–21]. It refers that various compo-
nents of health services are provided by single or separ-
ate providers in one site. A wide range of literatures
suggested the benefits of the integrating MMT to
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general health care facilities in accordance to clinical
and public health perspectives. At patient level, this
model facilitated health care utilization, improved health
outcome, and treatment adherence [22–24]. At facility
level, performing integrated services may avoid duplicat-
ing services and reduce administrative cost by utilizing
fix components of facilities [25–29]. Besides, there are
still several barriers that hamper the access and
utilization of integrative clinics among drug users,
including stigma and discrimination by health workers,
acceptability of communities, the lack of comprehensive
health care services, and the organization capacity for
integration of different services [30–32].
In Vietnam, since the first MMT program was piloted
in 2008, 156 MMT clinics have been established and op-
erated with 28,000 DUs enrolling by April 2015 [33, 34].
With its large population of about 200,000 drug users,
the Government of Vietnam has a strong political will
and action plan to expand MMT services to cover
80,000 drug users by 2015 [7, 33, 35, 36]. Prior studies
illustrated the influences of MMT on drug use behav-
iors, quality of life, and health care expenditure of HIV-
positive PWUD [6, 8]. However, none of them took into
account the impact of diverse MMT delivery models. In
addition, the rapid cuts in foreign aids require Vietnam
to identify strategies to reduce the deficit in resources
for MMT as well as other HIV services and programs.
Reducing costs, improving efficiency, and mobilizing
resources from a wide variety of sources are potential
policy options of which evidence on factors associated
with the outcomes of service integration is necessary.
The current organization of health service delivery sys-
tem in Vietnam includes four levels: central, provincial,
district, and commune [37]. Currently, MMT services
are set up as a stand-alone site or integrated with pro-
vincial AIDS center (PAC), district health center (DHC),
or regional polyclinics (RPC) which is a district-level
health facility providing primary and secondary health
care services for multiple communes far from the DHC
[37]. The purposes of this study were to examine behav-
ioral and health-related quality-of-life (HRQOL) out-
comes of MMT in different service delivery models and
explore the factors associated with these outcomes of
interest.
Methods
Study settings and sampling
From January to August 2013, a cross-sectional survey
was conducted in two HIV epicenters in Vietnam: Hanoi
and Nam Dinh, with 20,717 and 3685 HIV-positive
reported cases, respectively. Five clinics were purposively
selected in Hanoi and Nam Dinh Provinces. These set-
tings were selected based on some criteria: (1) providing
MMT services; (2) covering a wide range of health care
levels such as provincial, regional, and district levels; and
(3) having adequate patients for the study. These sites
were classified into four delivery models:
(1)MMT +HIV voluntary testing and counseling
services (VCT) at Nam Dinh PAC;
(2)MMT + rural DHC in Xuan Truong District,
(3)MMT + urban DHC in Tu Liem and Long Bien
districts, and
(4)MMT + urban Ha Dong RPC.
Both rural and urban DHCs in this study provide
MMT along with antiretroviral treatment (ART) and
general health care. Meanwhile, the Ha Dong RPC only
provides general health care. During the period of this
study, those services were co-located in one site with
different health workers. Eligible subjects were 18 years
or above, participating or having demand to enroll into
the program. Patients meeting the criteria and present-
ing at the clinic during the whole study period were
invited; and if they agreed to participate, an informed
consent was given to them for signature. A total of 1016
respondents were recruited in the study. Since patients
in our sample were receiving MMT free-of-charge, they
did not receive any extra incentive for answering the
survey. The response rate was 80–90 % across different
sites (Table 1).
Measures and instruments
Socioeconomic status, high-risk behaviors, and HRQOL
of respondents were collected by face-to-face interview
using structured questionnaires. Behaviors of interest
include current drug use and condom use (last sexual
intercourse) with intimate, casual, and commercial sex
partners that were self-reported by respondents.
HRQOL was measured by using EuroQol - five dimen-
sions - five levels (EQ-5D-5L) instrument. The descrip-
tive system includes five domains: mobility, self-care,
usual activities, pain/discomfort, and anxiety/depression
with five levels of response: no problems, slight prob-
lems, moderate problems, severe problems, and extreme
problems, giving 3125 health states with respective sin-
gle indexes. To compute those indexes, the EQ-5D-5L
value set of Thailand was used in the absence of such
values for Vietnam [38]. Additionally, the EuroQol - Vis-
ual Analog Scale (EQ-VAS) assesses the self-rated health
of respondents in a scale from 0 to 100 points, labeled
“the best health you can imagine” and “the worst health
you can imagine.” The Vietnamese version of EQ-5D-5L
was translated and has been widely applied in HIV and
drug use populations of Vietnam [8, 15, 33, 38–40]. EQ-
5D-5L and EQ-VAS have been shown to perform good
measurement properties and be responsive in monitoring
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the health status of HIV-affected patients groups in
Vietnam [5, 15, 33, 38–40].
Statistical analysis
ANOVA and chi-squared test were used to assess the
difference of characteristics and behavioral and HRQOL
outcomes between different MMT models. Multivariate
linear regression and logistic regression were performed
to determine the factors related to outcomes of interest.
Predictors of outcomes included sociodemographic char-
acteristics, history of drug use and rehabilitation, health
status and HIV infection, current drug-related behaviors,
and service delivery models. Backward stepwise selection
strategy was used to reduce the models, with variables
having p values of log-likelihood ratio test <0.1 included.
Statistical significance was set at p value <0.05.
Ethical approval
The research was approved by the Scientific Committee
of the Authority of HIV/AIDS Control, Ministry of
Health, Vietnam.
Results
A total of 1016 patients enrolled into the study, 997 tak-
ing MMT daily for average 16.5 months; 19 other pa-
tients were not included in this analysis since they had
registered but not yet taken methadone. There were
19.7 % of the patients taking MMT for over 24 months;
and 3.3 % were treated for 36–60 months. The mean age
of patients was 36.7 (SD = 7.6) years. Among those, only
1.28 % were female, 67.7 % lived with spouse or partners.
The majority had less than high school education
(55.3 %) and cult of ancestors (or ancestral veneration)
(88.2 %). The percentage of participants reporting HIV-
positive status was 8.1 %. Compared to other sites, the
rural MMT clinics integrated with Xuan Truong DHC
have a large proportion of patients who were Catholic
(25.8 %) and who were manual workers or farmers
(35.8 %) (Table 2).
In Table 3, history of drug use and previous drug use
rehabilitation are compared among patients of four ser-
vice models. On average, patients used drug for the first
time at the age of 24.1 (SD = 6.5), for 13.5 years, and had
about five episodes of drug rehabilitation prior to the
MMT. Patients at the rural MMT clinic started using
drugs at earlier ages and experienced fewer times of drug
rehabilitation than patients at other clinics. The location
of rehabilitation included self-management at home
(71.6 %), voluntary centers (47.8 %), and compulsory cen-
ters (27.2 %). As for the reason for relapse, craving and
peer inducement were the two major causes as reported
by half of the patients.
Table 4 presents the current drug use, condom use,
and self-reported HRQOL of patients participating in
each MMT model. We found heterogeneity in these out-
comes across different service models, but it was largely
contributed by geographical location. There were less
than 5 % of the patients who reported current drug use
during MMT; however, it was the highest in the rural
MMT integrated with Xuan Truong DHC (13.1 %).
Among sexually active individuals, most services also,
the percentage of patients using condom (last sexual
intercourse) with their primary and casual partners was
lowest in urban MMT at DHC in comparison with other
clinics. Overall, 95.4 % of the patients reported that their
HRQOL had improved to some extent over MMT. The
proportion of patients who reported having any health
problem across five dimensions of the EQ-5D instru-
ment in the rural areas was double than that of all
patients in the sample. Patients who were attending the
urban MMT integrated with Ha Dong RPC reported
smallest proportions of all health problems among
selected sites.
Table 5 explored the related factors with current drug
use and HRQOL of MMT patients in the reduced linear
regression models. These models specified the associ-
ation between service models and duration of MMT
with the outcomes of interest while adjusting for other
covariates. Although no significant difference in current
drug use between service models was found, MMT
clinics integrated with urban DHC and RPC showed bet-
ter HRQOL outcome measured using VAS, and the rural
MMT showed the lowest EQ-5D index score. Duration
on MMT is also associated with reduced likelihood of
current drug use among those retained on MMT, while
having any problems in mobility (OR = 4.2) and anxiety/
depression (OR = 3.1) during MMT substantially increased
the risk of current drug use.
There are several sociodemographic factors and history
of drug use associated with HRQOL outcomes of MMT.
Table 1 Characteristics of study sites
Level Settings Site name Type of services Sample size
Province Nam Dinh City Provincial AIDS center MMT + VCT 270
District (rural) Xuan Truong District District health center MMT + VCT + ART + GH 151
District (urban) Tu Liem District District health center MMT + VCT + ART + GH 201
District (urban) Long Bien District District health center MMT + VCT + ART + GH 184
District (urban) Ha Dong District Regional polyclinic MMT + GH 210
Tran et al. Harm Reduction Journal  (2016) 13:4 Page 3 of 9
Unemployment, HIV-positive status, concurrent drug use,
and higher numbers of previous drug rehabilitation epi-
sodes were associated with decreased HRQOL among
MMT patients.
Discussion
While integration and decentralization of HIV/AIDS
and substance abuse treatment services with existing
health care delivery system is critical in sustaining efforts
to fight HIV/AIDS in large injection-driven epidemics,
findings of this study showed a significant heterogeneity
in outcomes of MMT across different service models.
However, variability in MMT outcomes was largely con-
tributed by the geographical differences. Although previ-
ous studies determined that long-term MMT in general
will bring about improvements in health status and
reduce the likelihood of concurrent drug use among pa-
tients [41]; we found poorer HRQOL outcomes in rural
or lower level MMT clinics. If the goal is to engage drug
users with MMT in a timely manner and prevent HIV
transmission, it is necessary that not only HIV-related
interventions but also general health care should be pro-
vided [13, 35, 36, 42]. These findings support current
policies on scaling up MMT program in Vietnam and
inform the development of more comprehensive care
and support services for drug users as well as building
capacity of health workers in substance abuse treatment
in large drug-using populations.
This is the first study profiling the outcomes of dif-
ferent integrative models for delivering MMT. It con-
tributes to the literature empirical evidence that the
integration of MMT with existing health care services
Table 2 Sociodemographic characteristics of respondents
MMT + VCT + ART + DGH
MMT + VCT Rural Urban MMT + RPC All p value
Mean SD Mean SD Mean SD Mean SD Mean SD
Age 36.8 7.3 36.8 8.0 36.4 7.9 37.0 7.5 35.8 7.5 0.83
N % N % N % N % N %
Sex (male) 266 98.5 151 100.0 206 98.1 380 98.7 1003 98.7 0.44
Educational attainment
Illiterate 4 1.5 1 0.7 4 1.9 8 2.1 17 1.7 <0.01
Elementary 21 7.8 29 19.2 27 12.9 42 10.9 119 11.7
Secondary 103 38.2 87 57.6 86 41.0 150 39.0 426 41.9
High 121 44.8 28 18.5 81 38.6 157 40.8 387 38.1
Vocational 12 4.4 5 3.3 7 3.3 8 2.1 32 3.2
University 9 3.3 1 0.7 5 2.4 20 5.2 35 3.4
Marital status
Single 101 37.4 29 19.2 47 22.4 74 19.2 251 24.7 <0.01
Live with spouse 148 54.8 116 76.8 147 70.0 274 71.2 685 67.4
Live with partner 0 0.0 0 0.0 1 0.5 2 0.5 3 0.3
Divorced 19 7.0 6 4.0 15 7.1 32 8.3 72 7.1
Widow 2 0.7 0 0.0 0 0.0 3 0.8 5 0.5
Religion
Cult of ancestors 247 91.5 96 63.6 198 94.3 355 92.2 896 88.2 <0.01
Buddhism 13 4.8 16 10.6 10 4.8 20 5.2 59 5.8
Catholic 10 3.7 39 25.8 2 1.0 5 1.3 56 5.5
Protestant 0 0.0 0 0.0 0 0.0 5 1.3 5 0.5
Employment
Unemployed 76 28.2 25 16.6 53 25.2 105 27.3 259 25.5 <0.01
Self-employed 159 58.9 67 44.4 112 53.3 204 53.0 542 53.4
White collars 5 1.9 1 0.7 5 2.4 11 2.9 22 2.2
Workers, farmers 10 3.7 54 35.8 18 8.6 18 4.7 100 9.8
Students 0 0.0 0 0.0 0 0.0 2 0.5 2 0.2
Other jobs 20 7.4 4 2.7 22 10.5 45 11.7 91 9.0
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will yield better outcomes [36, 43]. In literatures, integra-
tion has potential roles to facilitate the continuity of care
and increased access to medical services [19, 44–46].
Besides, patients participating in this model have lower
costs for health care due to fewer admissions to hospitals,
reducing their health care expenditure and household
economic burden [8, 33, 47]. Those reasons may results in
better health outcomes of patients in integrated clinics at
PRC and urban DHC compared to other clinics.
This study reaffirms the reduced drug use behaviors
over the course of MMT that support previous study on
the cost-effectiveness of short-term MMT for drug users
Table 3 History of drug use and rehabilitation
MMT + VCT + ART + DGH
MMT + VCT Rural Urban MMT + RPC All p value
Mean SD Mean SD Mean SD Mean SD Mean SD
History of drug use
Age first used drug 24.3 7.0 26.6 7.4 25.3 6.7 23.5 6.1 24.1 6.5 0.21
Time since first episode (year) 13.5 5.1 11.2 5.3 12.2 5.9 14.5 6.2 13.5 5.7 <0.01
Time since first drug injection (year) 10.9 4.4 7.9 3.9 9.2 4.6 11.0 5.5 10.9 4.9 0.02
Drug rehabilitation
Number of episodes 5.7 7.2 3.4 3.0 4.2 5.2 5.1 6.9 4.8 6.2 0.02
N % N % N % N % N %
Location of rehabilitation
Home, self-managed 213 85.9 103 75.7 132 68.8 226 61.8 674 71.6 <0.01
Voluntary centers 108 43.6 50 36.8 97 50.5 195 53.3 450 47.8 <0.01
Compulsory centers 74 29.8 13 9.6 32 16.7 137 37.4 256 27.2 <0.01
Reason for relapse
Boredom 91 36.7 31 22.8 80 41.7 162 44.3 364 38.6 <0.01
Peer inducement 115 46.4 67 49.3 106 55.2 189 51.6 477 50.6 0.30
Craving 107 43.2 62 45.6 96 50.0 168 45.9 433 46.0 0.56
Unemployment 11 4.4 3 2.2 6 3.1 29 7.9 49 5.2 0.02
Table 4 Behavioral and quality-of-life outcomes by different service models
MMT + VCT + ART + DGH
MMT + VCT Rural Urban MMT + RPC All p value
N % N % N % N % N %
Concurrent drug use 15 5.6 17 11.3 11 5.2 6 1.6 49 4.8 <0.01
Condom use (last sexual intercourse)
Intimate partners 58 30.4 40 30.5 30 17.4 97 31.7 225 28.1 0.01
Casual partners 6 75.0 11 64.7 4 30.8 14 60.9 35 57.4 0.15
Commercial sex partners 16 94.1 16 88.9 11 91.7 28 77.8 71 85.5 0.35
Improved QOL 255 94.8 132 97.1 205 97.6 360 94.0 952 95.4 0.18
Reported health problems
Mobility 19 7.0 20 13.3 15 7.1 20 5.2 74 7.3 0.02
Self-care 10 3.7 9 6.0 9 4.3 12 3.1 40 3.9 0.49
Usual activities 18 6.7 17 11.3 9 4.3 16 4.2 60 5.9 0.01
Pain or discomfort 37 13.7 57 37.8 34 16.2 52 13.5 180 17.7 <0.01
Anxiety or depression 56 20.7 65 43.1 38 18.1 51 13.3 210 20.7 <0.01
Mean SD Mean SD Mean SD Mean SD Mean SD Mean
Health utility
EQ-5D single index 91.2 15.1 82.7 16.5 91.4 15.3 93.3 13.4 83.4 20.5 <0.01
VAS 76.4 15.3 75.8 16.2 78.8 14.3 78.3 13.0 74.8 16.8 0.09
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regardless of their HIV status [5, 7]. The overall HRQOL
score measured using EQ-5D in this study was higher
than HIV-positive drug users taking MMT and lower than
the general population in Vietnam [6, 8, 14, 15, 38, 39].
However, patients attending rural or decentralized services
had clinically important differences in HRQOL compared
to others. We observed a very high proportion of having
problems in pain/discomfort and anxiety/depression and
notably in mobility among patients attending MMT at the
rural DHC. The proportion of having any problem in
Table 5 Factors associated with concurrent drug use and quality-of-life outcomes of MMT
EQ-5D index VAS Concurrent drug use
Coefficient 95 % CI Coefficient 95 % CI OR 95 % CI
MMT model (MMT + VCT - reference)
Rural MMT-ART-VCT-DGH −4.7** (−8.7; −0.6) 1.4 (−2.1; 4.9) 0.39 (0.08; 1.94)
Urban MMT-ART-VCT-DGH 1.2 (−1.8; 4.1) 4.0*** (1.3; 6.7) 0.96 (0.30; 3.04)
MMT +regional polyclinic −0.1 (−3.1; 2.9) 3.7*** (0.9; 6.4) 2.38 (0.90; 6.26)
Duration of MMT (years) 0.01 (−0.1; 0.1) −0.1* (−0.2; 0.0) 0.91*** (0.86; 0.96)
Reported HIV status
Positive vs. negative −4.6*** (−7.8; −1.5)
Reported health problems (yes vs. no)
Mobility 4.20** (1.41; 12.51)
Anxiety or depression 3.09** (1.27; 7.53)
Concurrent drug use
Yes vs. no −9.2*** (−14.7; −3.7) −7.3*** (−12.3; −2.4) N/A
History of drug rehabilitation
Number of episodes −0.2** (−0.4; −0.0)
Education (illiterate - reference)
Elementary 14.4*** (5.8; 22.9)
Secondary 14.7*** (6.5; 22.9)
High 14.7*** (6.5; 22.9)
Vocational 13.6*** (3.6; 23.6)
University 15.4*** (5.6; 25.3)
Marital status (single - reference)
Widow −16.2* (−32.8; 0.3)
Religion (cult of ancestors - reference)
Buddhism −4.0* (−8.8; 0.7)
Catholic −7.2*** (−12.5; −1.8)
Employment (unemployed - reference)
Self-employed 2.3** (0.1; 4.4) 5.4*** (3.2; 7.7)
White collars 11.6*** (3.2; 20.0)
Workers, farmers 3.9* (−0.1; 7.9)
Other jobs 4.2** (0.4; 8.0)
Age group (18 to <25 - reference)
25 to <30 6.9*** (3.0; 10.8)
30 to <35 6.9*** (3.4; 10.4) −2.8* (−5.7; 0.1) 2.26* (0.99; 5.18)
35 to <40 4.9*** (1.4; 8.4) −3.9** (−6.9; −0.9)
40 to <45 7.0*** (3.0; 11.0) −4.1** (−7.5; −0.7)
45 and above −11.8*** (−15.4; −8.3)
Constant 72.0*** (63.1; 80.9) 77.7*** (74.4; 81.0)
CI in parentheses
***p < 0.01; **p < 0.05; *p < 0.1
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mobility of the general population and HIV-positive group
was 2.1 and 7.5 %, respectively [15]. In measuring health-
related quality of life, VAS is a valid measure that captures
the values of patients attached to their current health
states which is no different than the gold standard method
for measuring preference-based HRQOL—the Standard
Gamble [39]. VAS score had not increased over long-term
MMT that could be explained by the fact that drug users
receiving MMT still have many other social, economic,
and health concerns [6, 13, 14, 38, 48]. As observed in pre-
vious studies in Vietnam, we found that HIV status,
current drug use, history of drug rehabilitation, duration
of drug use prior to MMT, and various socioeconomic
characteristics of respondents were significantly associated
with HRQOL outcomes [6, 8, 13–15, 38, 48–50].
Integration has been raised as a priority in the context
of limited resources for HIV/AIDS responses [35, 36, 51].
In economic theory, this model has the potential advan-
tages on technical (focusing on unit cost of services) and
allocative efficiency (focusing on cost-effectiveness of ser-
vices) [52]. Recent studies confirmed that integrated HIV/
AIDS service delivery was more efficient than stand-alone
services [9, 20]. However, none of them mentioned the
efficiency of integrated MMT services with general/pri-
mary health care. Findings of this study have implications
to inform the expansion and management of MMT ser-
vices in Vietnam. First, the majority of patients registering
at new MMT sites might be younger and have more phys-
ical and mental health problems. Depression and other
mental disorders have been known as a predictor of drug
relapse and HIV risk behaviors and negatively affect anti-
retroviral treatment outcomes [53–55]. Therefore, inte-
grating MMT clinics with general health care facilities is
necessary, and general health care and psychological sup-
port should be provided to drug users prior to and during
MMT. Second, in the rural areas, the long distance to
MMT clinics can be a barrier to the access and adherence
of patients. It is important to notice that in this analysis,
13.3 % of the patients have problems in mobility, and this
group is about four times more likely to use drugs concur-
rently than their counterpart. Since patients require daily
uptake of the medication, a satellite model that links the
MMT at DHC with commune health stations for deliver-
ing MMT in large drug-using populations could be highly
efficient. Besides, take-home dose may also be an option
that helps overcome the geographical barriers and im-
prove adherence of patients. However, with the current
policies, the management and delivery of methadone
medication that does not support the implementation of
take-home dose in short term is restricted.
The strength of this study was the participation of a
large sample size in various levels of the health care sys-
tem. In addition, validated instruments (EQ-5D-5L and
VAS) were employed to allow for the comparability of
measurements. However, the study has limitations. First,
the cross-sectional design may not allow the causal rela-
tions between MMT delivery models and the changes of
HRQOL as well as risk behaviors of respondents. Second,
the collected data was based on self-reported information,
which was subject to desirability bias due to respondents’
recall. In this study, concurrent drug use was self-reported
that might underestimate the actual prevalence among
MMT patients. In addition, we only interviewed the
patients who remained at the MMT clinics while missing
those who dropped out of the program. In addition, we
did not have information regarding MMT doses and
patient responses. Finally, the generalization of study was
limited due to convenience sampling technique.
Conclusions
In conclusion, the study supports the effectiveness of
MMT for drug users in Vietnam and preferable out-
comes of integrating MMT with existing health services.
Heterogeneities in behavioral and HRQOL outcomes
across different integrative MMT service models suggest
a need not only to provide HIV-related interventions but
also the value of comprehensive health care including
psychological supports for MMT patients especially in
rural areas. Future research should examine the costs
and efficiency of satellite models for dispensing MMT
where distance to the clinic is a barrier to service access
and utilization.
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